EVALUATION OF THE EFFICACY OF SGLT2 INHIBITOR THERAPY IN PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION
Fuente:
Zenodo
Saved in:
| Main Authors: | Cotoneț, Tatiana, Cabac-Pogorevici, Irina |
|---|---|
| Format: | Recurso digital |
| Language: | Romanian, Moldovan |
| Published: |
Zenodo
2025
|
| Subjects: | |
| Online Access: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
CHRONIC HEART FAILURE: MODERN DIAGNOSTIC AND THERAPEUTIC APPROACHES
by: Salohiddinova Hojaroy, et al.
Published: (2025)
by: Salohiddinova Hojaroy, et al.
Published: (2025)
Dapagliflozin – derribando barreras en el tratamiento actual de la diabetes mellitus
by: Nadia Shiguango Shiguango
Published: (2020)
by: Nadia Shiguango Shiguango
Published: (2020)
Sodium-Glucose Co-Transporter Type 2 Inhibitors and Heart Failure: A Review of the State of the Art
by: Yilmar Alexader Meza-González
Published: (2023)
by: Yilmar Alexader Meza-González
Published: (2023)
Safety of SGLT2 inhibitors in very elderly diabetic type 2 patients in real life
by: Ramón Baeza-Trinidad
Published: (2023)
by: Ramón Baeza-Trinidad
Published: (2023)
Características diferenciales del empagliflozin en el tratamiento de la diabetes mellitus
by: Vicente David Aguilera Moreira
Published: (2021)
by: Vicente David Aguilera Moreira
Published: (2021)
The Association of SGLT-2 inhibitors (Empagliflozin) with the development of hypernatremic dehydration: a case report
by: Diana Alegre-González
Published: (2025)
by: Diana Alegre-González
Published: (2025)
Patterns of Left Ventricular Geometry and The Transition to Congestive Heart Failure With Preserved Versus Depressed Ejection Fraction
by: Diego F. Dávila
Published: (2014)
by: Diego F. Dávila
Published: (2014)
Epigenetic Regulation of Cardiovascular Physiology: Role of DNA Methylation and Histone Modification in Heart Failure Pathogenesis and Therapy
by: Ramyashree Narayana*, Shivprasad Sanjay Dhage
Published: (2026)
by: Ramyashree Narayana*, Shivprasad Sanjay Dhage
Published: (2026)
Digoxin’s roles in heart failure patients. An overview
by: Estêvão Lanna Figueiredo
Published: (2010)
by: Estêvão Lanna Figueiredo
Published: (2010)
Can MAPSE measurements be used to predict outcomes in patients with left ventricular heart failure?
by: Tripdatabase
Published: (2026)
by: Tripdatabase
Published: (2026)
Should dapagliflozin be discontinued before a surgical procedure?
by: Tripdatabase
Published: (2025)
by: Tripdatabase
Published: (2025)
Biomarkers for predicting rehospitalization in acute decompensated heart failure
by: Borizanova-Petkova, A., et al.
Published: (2025)
by: Borizanova-Petkova, A., et al.
Published: (2025)
Hope in elderly adults with chronic heart failure. Concept analysis
by: Meriam F. Caboral
Published: (2012)
by: Meriam F. Caboral
Published: (2012)
What are the risks of combined sitagliptin and dapagliflozin in type 2 diabetes patients?
by: Tripdatabase
Published: (2025)
by: Tripdatabase
Published: (2025)
ESC Heart Failure
Published: (2015)
Published: (2015)
Visión integral de la farmacología de los inhibidores de los co-transportadores de sodio/glucosa: pasado, presente y futuro
by: Alex Patricio Morales Carrasco
Published: (2020)
by: Alex Patricio Morales Carrasco
Published: (2020)
What is the relationship between serum potassium levels and mortality in patients with acute heart failure?
by: Tripdatabase
Published: (2026)
by: Tripdatabase
Published: (2026)
Valvular heart disease during pregnancy: a clinical case and a literature review
by: Diana Bužinskienė
Published: (2018)
by: Diana Bužinskienė
Published: (2018)
Current treatment for heart failure with reduced ejection fraction. A systematic review of the new therapies
by: JAIRO ALFONSO GÁNDARA-RICARDO
Published: (2021)
by: JAIRO ALFONSO GÁNDARA-RICARDO
Published: (2021)
What is the role of aminophylline in patients with congestive heart failure who are also receiving diuretic therapy?
by: Tripdatabase
Published: (2026)
by: Tripdatabase
Published: (2026)
Clinical-functional changes of myocardium after percutaneous coronary interventions in patients with chronic heart failure
by: Olga A. Efremova
Published: (2019)
by: Olga A. Efremova
Published: (2019)
Treatment of acquired arteriovenous fistula with severe hemodynamic effects: therapeutic challenge
by: Bruna Ferreira Pilan
Published: (2014)
by: Bruna Ferreira Pilan
Published: (2014)
Restrictive cardiomyopathy. Presentation of seven cases
by: Luis Alfonso Fonseca-Sánchez
Published: (2014)
by: Luis Alfonso Fonseca-Sánchez
Published: (2014)
Diabetes mellitus in patients with heart failure and effect modification of risk factors for short-term mortality: An observational study from the Registro Colombiano de Falla Cardíaca (RECOLFACA)
by: Luis Eduardo Echeverría
Published: (2024)
by: Luis Eduardo Echeverría
Published: (2024)
Cost-effectiveness analysis and medication use for gangrene treatment in type 2 diabetes patients: A systematic literature review
by: Sutrisno, Entris, et al.
Published: (2025)
by: Sutrisno, Entris, et al.
Published: (2025)
SGLT2 Inhibitors: Pharmacology and Expanding Role Beyond Diabetes
by: Shivcharan Kamble*, Rashee Shahu, Sunita Kode, Tejaswini Gaikwad, Pooja Rasal
Published: (2026)
by: Shivcharan Kamble*, Rashee Shahu, Sunita Kode, Tejaswini Gaikwad, Pooja Rasal
Published: (2026)
A retrospective characterization of worsening renal function in patients with acute decompensated heart failure receiving nesiritide
by: Jessica A. STARR
Published: (2009)
by: Jessica A. STARR
Published: (2009)
Cardiac Failure Review
Published: (2020)
Published: (2020)
Hearts
Published: (2020)
Published: (2020)
Cardiovascular and Cardiometabolic Journal
Published: (2025)
Published: (2025)
Cystatin C as Marker of Cardiorenal Syndrome and Poor Prognosis in Patients Hospitalized with Acute Heart Failure and Normal Renal Function
by: IVÁN CONSTANTIN
Published: (2016)
by: IVÁN CONSTANTIN
Published: (2016)
IDENTIFICACIÓN Y EVALUACIÓN DE TRANSPORTADORES DE GLUCOSA SGLT1 Y GLUT2 Y LA INCRETINA GLP-1 EN INTESTINO DELGADO DE CUYES (Cavia porcellus)
by: Juan Anglas P.
Published: (2012)
by: Juan Anglas P.
Published: (2012)
Международный журнал сердца и сосудистых заболеваний
Published: (2022)
Published: (2022)
Are there specific treatments for depression that are safe and effective in patients with congestive heart failure?
by: Tripdatabase
Published: (2025)
by: Tripdatabase
Published: (2025)
Impact of anemia on the association between red cell distribution width and 1-year mortality in acute heart failure patients
by: Maita-Arauco, Sherelym Alessandra, et al.
Published: (2026)
by: Maita-Arauco, Sherelym Alessandra, et al.
Published: (2026)
Interval and continuous exercise enhances aerobic capacity and hemodynamic function in CHF rats
by: Ramiro B. Nunes
Published: (2015)
by: Ramiro B. Nunes
Published: (2015)
Effects of warming yang and invigorating qi prescription on renin-angiotensin-aldosterone system in rats with heart failure after myocardial infarction
by: Lihua HAN
Published: (2017)
by: Lihua HAN
Published: (2017)
Cardiac resynchronization therapy in a patient with pacemaker-induced cardiomyopathy
by: María Camila Luna-España
Published: (2019)
by: María Camila Luna-España
Published: (2019)
The use of hypoxene in the treatment of patients with chronic heart failure
by: Hizir M. Bataev
Published: (2019)
by: Hizir M. Bataev
Published: (2019)
Trifascicular block in patient with acute coronary syndrome
by: Carlos Rafael Almira-Gómez
Published: (2020)
by: Carlos Rafael Almira-Gómez
Published: (2020)
Similar Items
-
CHRONIC HEART FAILURE: MODERN DIAGNOSTIC AND THERAPEUTIC APPROACHES
by: Salohiddinova Hojaroy, et al.
Published: (2025) -
Dapagliflozin – derribando barreras en el tratamiento actual de la diabetes mellitus
by: Nadia Shiguango Shiguango
Published: (2020) -
Sodium-Glucose Co-Transporter Type 2 Inhibitors and Heart Failure: A Review of the State of the Art
by: Yilmar Alexader Meza-González
Published: (2023) -
Safety of SGLT2 inhibitors in very elderly diabetic type 2 patients in real life
by: Ramón Baeza-Trinidad
Published: (2023) -
Características diferenciales del empagliflozin en el tratamiento de la diabetes mellitus
by: Vicente David Aguilera Moreira
Published: (2021)